Latest Capital Efficiency News

Pepper Money Limited reported a 2% increase in net profit after tax to $47 million for the half-year ended June 2025, driven by strong loan originations and disciplined cost management. The company also raised its interim dividend to 6.4 cents per share, signaling confidence despite a slight dip in net interest income.

Vault Minerals has initiated a disciplined on-market share buy-back program of up to 10% of its shares, reflecting confidence in its strong balance sheet and undervalued stock price.

Northern Star Resources delivered a standout FY25 with soaring revenue and EBITDA, bolstered by the strategic acquisition of De Grey Mining and promising FY26 guidance.

Heartland Group Holdings Limited reported an underlying NPAT of NZD 46.9 million for FY2025, meeting guidance, while setting ambitious growth and efficiency targets for FY2026.

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.

Dexus’s 2025 annual results reveal stable cash flows, robust occupancy rates, and a positive shift in property valuations, underscoring its resilience amid evolving market conditions. The company’s sustainability leadership and strategic divestments position it well for the next growth phase.

Emeco Holdings reports robust FY25 results marked by solid revenue growth, margin expansion, and significant debt reduction, setting the stage for continued operational focus and moderate earnings growth in FY26.

Cleanaway Waste Management delivered a robust FY25 with 14.6% EBIT growth and raised FY26 guidance, underpinned by key acquisitions and operational excellence.

Orbminco Limited is proposing a 20 – 1 consolidation of its issued shares to streamline its capital structure and broaden investor appeal, with shareholder approval sought in September.

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.

BHP Group Limited reported record iron ore and copper production for FY2025, underpinned by operational excellence and disciplined capital allocation. The company outlined growth project updates, maintained strong margins, and reaffirmed its decarbonisation and social value commitments.

BHP Group Limited reported strong FY2025 financial results driven by record copper production and operational excellence, while advancing key growth projects and sustainability goals. The company maintained its dividend payout and navigated cost escalations at the Jansen potash project alongside ongoing Samarco dam failure remediation.